New health concerns about 'fake pot' in US

March 5, 2012 in Medications

A type of fake pot has raised new health concerns in the United States after at least three users were hospitalized for kidney failure, authorities in the western state of Wyoming said Monday.

Often known as "Spice" or "K2," the substance is marketed to young people as herbal incense, and creates a marijuana-like high when it is smoked like a joint or a cigarette.

"At this point we are viewing use of this drug as a potentially life-threatening situation," Tracy Murphy, state epidemiologist with the Wyoming Department of , said in a statement sent to AFP.

State health authorities first learned of the latest incidents on Thursday involving three patients in central Wyoming who sought hospital care after smoking a product known as "blueberry spice," a spokeswoman added.

There have been no deaths and no reports of connected cases in other areas, she added.

However, drug say that fake pot use has been on the rise in recent years, ever since it was first copied from a US scientist's lab research in the mid 1990s and quickly spread around the world.

The compound, known as JWH-018, was created in the lab of John Huffman, a professor of at Clemson University, who was researching how marijuana-like compounds act on .

According to the US Drug Enforcement Agency, which in 2011 banned JWH-018 and four other synthetic , calls to poison control centers rose from just over 100 in 2009 to more than 2,700 nationwide in the space of a year.

"Technically it is an incense, it is not for , you know what I am saying?" said a smoke shop owner in Arizona who asked not to be named.

He said he continues to stock three kinds of herbal incense, but none that carry ingredients outlawed by the DEA.

"If there is a banned substance in there, then we don't have it in our store," he told AFP by phone, adding that brands and popularity change frequently.

"You know, people go from their K2 to their Dead Man Walking, to their Smoking Camel, there is all kinds of stuff out there," he said.

"I'll be happy when it's gone."

(c) 2012 AFP

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

Medications created 7 hours ago | popularity not rated yet | comments 0

Merck ends development of Parkinson's disease drug

(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.

Medications created May 23, 2013 | popularity 1 / 5 (1) | comments 0

J&J expects 10-plus new drug applications by 2017

(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...

Medications created May 23, 2013 | popularity 5 / 5 (1) | comments 0

Experts favor US approval of Merck sleeping pill (Update)

An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.

Medications created May 22, 2013 | popularity not rated yet | comments 0

Glaxo, US partnering to develop new antibiotics

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

Medications created May 22, 2013 | popularity not rated yet | comments 0


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Driving and hands-free talking lead to spike in errors, study shows

Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.